News

News

No. Title Written by Date Read
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 261,553
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 264,584
6 STCube Attracts Investment of 42 Billion Won, “Accelerating Development of Anti-cancer Immunotherapies Admin 18.04.25 261,294
5 A Road to Conquering Cancer — Successful Development of Antibody Drug as Potential Cure for Difficult-to-Treat Cancer Admin 18.02.13 322,358
4 Global Patent Application Made for STCube’s Novel Anti-cancer Immunotherapy Admin 17.11.23 261,203
3 STCube to Collaborate with U.S. Based Diviner Therapeutics for New Development of Novel Anticancer Immunotherapeutics Admin 17.10.31 600,111
2 STCube Completes Early-Stage License Out of its PD-L1 Antibodies in China and Taiwan Admin 17.10.19 261,197
1 STCube Publishes in the July Issue of The Journal Of Thoracic Oncology Admin 14.07.23 261,154